Effect of ozone gas on viral kinetics and liver histopathology in hepatitis C patients

Bibliographic Information
Authors: Sadek A.; Abd El Hady A.M.; Olfat H.; Abd El Hady A.A.; Wafy W.; Zaki M.; Youness E.R.
Journal: Journal of Complementary and Integrative Medicine
Publisher: Walter de Gruyter GmbH
Publication Date: 10 January 2024
Volume / Issue: Volume 21 / Issue 1
Pages: 131–138
ISSN: 15533840
Scopus: View on Scopus
PubMed: 38190482
Document Type: Article
Authors and Affiliations
Sadek A., Departments of Hepatology & Gastroenterology, Theodor Bilharz Research Institute, Giza, Egypt; Abd El Hady A.M., Departments of Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Olfat H., Departments of Pathology, Theodor Bilharz Research Institute, Giza, Egypt; Abd El Hady A.A., Departments of Clinical Chemistry, Theodor Bilharz Research Institute, Giza, Egypt; Wafy W., Departments of Public Health, Theodor Bilharz Research Institute, Giza, Egypt; Zaki M., Department of Biological Anthropology, Medical Researches and Clinical Studies Institute, National Research Centre, Cairo, Egypt; Youness E.R., Department of Medical Biochemistry, Medical Researches and Clinical Studies Institute, National Research Centre, Cairo, Egypt
Abstract
Objectives: We examine how well ozone/oxygen gas therapy treats chronic hepatitis C patients with varying degrees of liver fibrosis. Also to study the effect of giving multiple anti-oxidants with the ozone/oxygen gas mixture, to see if this addition would have any additive or synergistic effect. Methods: Two hundred and twenty three patients with chronic hepatitis C. Liver biopsies were carried out at after 12 weeks of administering an ozone/oxygen gas mixture. Results: The mean stage of fibrosis decreased from 1.98 to 1.41 and the mean grade of inflammation decreased from 10.08 to 7.94, both with a p value less than 0.001. After 12 weeks of treatment, mean PCR values increased. No single significant complication was recorded in a total of >9,000 settings of ozone therapy. Conclusions: Ozone oxygen gas mixture is safe and effective in treatment of hepatic fibrosis due to chronic viral hepatitis C. © 2023 Walter de Gruyter GmbH, Berlin/Boston.
Keywords
anti-oxidants; chronic liver disease; hepatitis C; liver fibrosis; ozone/oxygen gas mixture; Hepatitis C, Chronic; Humans; Liver; Liver Cirrhosis; Oxygen; Ozone; alanine aminotransferase; alkaline phosphatase; alpha tocopherol; ascorbic acid; aspartate aminotransferase; ubidecarenone; adult; aged; Article; chronic hepatitis C; controlled study; drug effect; drug efficacy; drug potentiation; drug safety; female; follow up; Hepatitis C virus; histopathology; human; human cell; human tissue; kinetics; liver biopsy; major clinical study; male; oxygen therapy; ozone therapy; phase 2 clinical trial; polymerase chain reaction; protein blood level; randomized controlled trial; single blind procedure; treatment duration; treatment response; viral kinetics; pathology
Citation Information
Scopus Citations: 2
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
